ARCHIVES

In Brief: NIH gives Advisors $50 Raise, Effective April 1, No Fooling

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | March 12, 1999

Download PDF Visit The Full Archive

Related Articles

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

Three cancer centers joined the Multiple Myeloma Research Consortium.

September 16, 2005

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

In Their Own Words: A 64-page Internal Report with over 1,500 Faculty Comments on MD Anderson Morale

March 29, 2013